Cargando…

CFTR Mutations Spectrum and the Efficiency of Molecular Diagnostics in Polish Cystic Fibrosis Patients

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane regulator gene (CFTR). In light of the strong allelic heterogeneity and regional specificity of the mutation spectrum, the strategy of molecular diagnostics and counseling in CF requires genetic tests to reflect the fre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziętkiewicz, Ewa, Rutkiewicz, Ewa, Pogorzelski, Andrzej, Klimek, Barbara, Voelkel, Katarzyna, Witt, Michał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935850/ https://www.ncbi.nlm.nih.gov/pubmed/24586523 http://dx.doi.org/10.1371/journal.pone.0089094

Ejemplares similares

Population specificity of the DNAI1 gene mutation spectrum in primary ciliary dyskinesia (PCD)
por: Ziętkiewicz, Ewa, et al.
Publicado: (2010)

Mutations in Radial Spoke Head Genes and Ultrastructural Cilia Defects in East-European Cohort of Primary Ciliary Dyskinesia Patients
por: Ziętkiewicz, Ewa, et al.
Publicado: (2012)

Correction: CFTR Mutations Spectrum and the Efficiency of Molecular Diagnostics in Polish Cystic Fibrosis Patients
Publicado: (2014)

ZMYND10 - Mutation Analysis in Slavic Patients with Primary Ciliary Dyskinesia
por: Kurkowiak, Małgorzata, et al.
Publicado: (2016)

Ciliary Genes Are Down-Regulated in Bronchial Tissue of Primary Ciliary Dyskinesia Patients
por: Geremek, Maciej, et al.
Publicado: (2014)

Heterogeneous Spectrum of CFTR Gene Mutations in Korean Patients with Cystic Fibrosis
por: Jung, Haiyoung, et al.
Publicado: (2011)

Analysis of CFTR Mutation Spectrum in Ethnic Russian Cystic Fibrosis Patients
por: Petrova, Nika V., et al.
Publicado: (2020)

European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients
por: Hryhorowicz, Szymon, et al.
Publicado: (2021)

Managing Cystic Fibrosis in Polish Healthcare
por: Rachel, Marta, et al.
Publicado: (2020)

Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)

Erratum: Heterogeneous Spectrum of CFTR Gene Mutations in Korean Patients with Cystic Fibrosis
Publicado: (2015)

Genetic attributes of Iranian cystic fibrosis patients: the diagnostic efficiency of CFTR mutations in over a decade
por: Hosseini Nami, Amin, et al.
Publicado: (2023)

Relating the Disease Mutation Spectrum to the Evolution of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
por: Rishishwar, Lavanya, et al.
Publicado: (2012)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2017)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
por: Moliteo, Evelina, et al.
Publicado: (2022)

CFTR modulators: transformative therapies for cystic fibrosis
por: Dwight, Mary, et al.
Publicado: (2021)

Shorter Diagnostic Delay in Polish Adult Patients With Common Variable Immunodeficiency and Symptom Onset After 1999
por: Ziętkiewicz, Marcin, et al.
Publicado: (2020)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Fixing cystic fibrosis by correcting CFTR domain assembly
por: Okiyoneda, Tsukasa, et al.
Publicado: (2012)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Lived experiences of individuals with cystic fibrosis on CFTR-modulators
por: Page, Annelise, et al.
Publicado: (2022)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Nutritional impact of CFTR modulators in children with cystic fibrosis
por: Gaschignard, Margaux, et al.
Publicado: (2023)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
por: Dobi, Dorina, et al.
Publicado: (2023)

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

In vitro culturing of ciliary respiratory cells—a model for studies of genetic diseases
por: Bukowy, Zuzanna, et al.
Publicado: (2010)

Recent advances in primary ciliary dyskinesia genetics
por: Kurkowiak, Małgorzata, et al.
Publicado: (2015)

Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
por: Shteinberg, Michal, et al.
Publicado: (2020)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
por: Fukuda, Ryosuke, et al.
Publicado: (2020)

Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis
por: Chanoux, Rebecca A., et al.
Publicado: (2012)

Predicting CFTR activity with front-runner cystic fibrosis drugs
por: Becq, Frédéric
Publicado: (2015)

The importance of CFTR expression for neutrophil function in patients with Cystic Fibrosis
por: Jundi, B, et al.
Publicado: (2015)

The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability
por: Meng, Xin, et al.
Publicado: (2016)

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias
Publicado: (2016)

Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
por: Chaudary, Nauman
Publicado: (2018)

Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis
por: Haq, Iram, et al.
Publicado: (2022)

The effect of CFTR modulators on structural lung disease in cystic fibrosis
por: Mok, L. Clara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vlk42jtevguagccjk27kijjlch